ORIC Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US68622P1093

SecurityORIC / ORIC Pharmaceuticals, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership710,861 shares
Latest Disclosed Value $ 9,006,608
Northern Trust Corp reports 19.72% decrease in ownership of ORIC / ORIC Pharmaceuticals, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 710,861 shares of ORIC Pharmaceuticals, Inc. (US:ORIC) valued at $9,006,609 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 885,475 shares of ORIC Pharmaceuticals, Inc.. This represents a change in shares of -19.72% during the quarter. The current value of the position is $5,701,105 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ORIC PHARMACEUTICALS COM 68622P109 710,861 -174,614 -19.72 9,007 24.34 0.0002
2026-02-17 2025-12-31 13F ORIC PHARMACEUTICALS COM 68622P109 885,475 -3,060 -0.34 7,243 -32.07 0.0002
2025-11-14 2025-09-30 13F ORIC PHARMACEUTICALS COM 68622P109 888,535 487,581 121.61 10,662 162.03 0.0003
2025-08-13 2025-06-30 13F ORIC PHARMACEUTICALS COM 68622P109 400,954 -145,792 -26.67 4,070 33.41 0.0006
2025-05-13 2025-03-31 13F ORIC PHARMACEUTICALS COM 68622P109 546,746 -7,247 -1.31 3,051 -31.77 0.0005
2025-02-14 2024-12-31 13F ORIC PHARMACEUTICALS COM 68622P109 553,993 28,079 5.34 4,471 -17.07 0.0006
2024-11-13 2024-09-30 13F ORIC PHARMACEUTICALS COM 68622P109 525,914 166,888 46.48 5,391 112.37 0.0009
2024-08-14 2024-06-30 13F ORIC PHARMACEUTICALS COM 68622P109 359,026 5,685 1.61 2,538 -47.76 0.0004
2024-05-14 2024-03-31 13F ORIC PHARMACEUTICALS COM 68622P109 353,341 144 0.04 4,858 49.52 0.0008
2024-02-13 2023-12-31 13F ORIC PHARMACEUTICALS COM 68622P109 353,197 10,297 3.00 3,249 56.65 0.0006
2023-11-13 2023-09-30 13F ORIC PHARMACEUTICALS COM 68622P109 342,900 4,969 1.47 2,075 -20.90 0.0004
2023-08-11 2023-06-30 13F ORIC PHARMACEUTICALS COM 68622P109 337,931 264,208 358.38 2,622 524.29 0.0005
2023-05-15 2023-03-31 13F ORIC PHARMACEUTICALS COM 68622P109 73,723 791 1.08 420 -2.10 0.0001
2023-02-13 2022-12-31 13F ORIC PHARMACEUTICALS COM 68622P109 72,932 -307 -0.42 430 83.33 0.0001
2022-11-14 2022-09-30 13F ORIC PHARMACEUTICALS COM 68622P109 73,239 714 0.98 234 -28.00 0.0001
2022-08-12 2022-06-30 13F ORIC PHARMACEUTICALS COM 68622P109 72,525 -226,333 -75.73 325 -79.64 0.0001
2022-05-13 2022-03-31 13F ORIC PHARMACEUTICALS COM 68622P109 298,858 -14,925 -4.76 1,596 -65.40 0.0003
2022-02-08 2021-12-31 13F ORIC PHARMACEUTICALS COM 68622P109 313,783 -3,025 -0.95 4,613 -30.36 0.0008
2021-11-15 2021-09-30 13F ORIC PHARMACEUTICALS COM 68622P109 316,808 38,917 14.00 6,624 34.74 0.0012
2021-08-13 2021-06-30 13F ORIC PHARMACEUTICALS COM 68622P109 277,891 47,134 20.43 4,916 -13.05 0.0009
2021-05-12 2021-03-31 13F ORIC PHARMACEUTICALS COM 68622P109 230,757 -6,290 -2.65 5,654 -29.54 0.0011
2021-02-11 2020-12-31 13F ORIC PHARMACEUTICALS COM 68622P109 237,047 131,125 123.79 8,024 202.91 0.0016
2020-11-16 2020-09-30 13F ORIC PHARMACEUTICALS COM 68622P109 105,922 -4,930 -4.45 2,649 -29.15 0.0006
2020-08-14 2020-06-30 13F ORIC PHARMACEUTICALS COM 68622P109 110,852 110,852 3,739 0.0009
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.